GLP-1 medications are designed to act on pathways involved in: Slower digestion and fullness cues Insulin response after meals Appetite signaling Blood sugar regulation Common GLP-1 medications include: Semaglutide Liraglutide Dulaglutide Tirzepatide A licensed provider may consider GLP-1 therapy for eligible patients with goals related to: Weight loss Prediabetes Type 2 diabetes Appetite control Metabolic support Your response depends on genetics, starting health, dosage, lifestyle habits, and how long GLP-1 stays active in your system
PBS listing: Pharmaceutical Benefits Scheme (PBS) listing is separate from TGA approval
It targets an entirely different set of neurons in the brain, creating what researchers call complementary satiety signaling
"Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: A randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial." The Lancet , 402(10404), 529-544
How GLP-1 Medications Support Long-Term Weight Management GLP-1 receptor agonists have been studied extensively in adults seeking a safe and predictable method to manage weight
At Be Well Medical Group, we provide personalized, physician-guided weight loss programs using: Semaglutide (Ozempic, Wegovy) Tirzepatide (Mounjaro, Zepbound) GLP-1 Weight Loss Near You We provide GLP-1 weight loss care in: - Beverly Hills - Los Angeles - West Hollywood - Santa Monica - Pasadena We also offer telehealth across California
